ScreenIT
The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.
Latest preprint reviews
-
Discrepancies in the detection of SARS-CoV-2 by qRT-PCR are dependent on the target gene used for its amplification: Implications in the diagnosis of clinical infection
This article has 8 authors:Reviewed by ScreenIT
-
Single‐cell transcriptomic atlas reveals distinct immunological responses between COVID‐19 vaccine and natural SARS‐CoV‐2 infection
This article has 18 authors:Reviewed by ScreenIT
-
Correlation between times to SARS-CoV-2 symptom onset and secondary transmission undermines epidemic control efforts
This article has 3 authors:Reviewed by ScreenIT
-
(Machine) Learning the mutation signatures of SARS-CoV-2: a primer for predictive prognosis
This article has 5 authors:Reviewed by ScreenIT
-
Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity
This article has 26 authors:Reviewed by ScreenIT
-
Vaccines alone are no silver bullets: a modeling study on the impact of efficient contact tracing on COVID-19 infection and transmission in Malaysia
This article has 5 authors:Reviewed by ScreenIT
-
Hybrid immunity versus vaccine-induced immunity against SARS-CoV-2 in patients with autoimmune rheumatic diseases
This article has 10 authors:Reviewed by ScreenIT
-
Colloidal Aggregators in Biochemical SARS-CoV-2 Repurposing Screens
This article has 5 authors:Reviewed by ScreenIT
-
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans
This article has 31 authors:Reviewed by ScreenIT
-
Odds of Testing Positive for SARS-CoV-2 Following Receipt of 3 vs 2 Doses of the BNT162b2 mRNA Vaccine
This article has 6 authors:Reviewed by ScreenIT